• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用4F引导导管进行非闭塞性冠状动脉血管内镜观察的可行性和安全性。

Feasibility and safety of non-occlusive coronary angioscopic observation using a 4 Fr guiding catheter.

作者信息

Matsushita Masato, Takano Masamichi, Munakata Ryo, Sawatani Tomofumi, Kurihara Osamu, Komiyama Hidenori, Murakami Daisuke, Shirakabe Akihiro, Kobayashi Nobuaki, Hata Noritake, Miyauchi Yasushi, Seino Yoshihiko, Shimizu Wataru

机构信息

Department of Cardiovascular Medicine, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.

Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.

出版信息

AsiaIntervention. 2018 Sep 20;4(2):110-116. doi: 10.4244/AIJ-D-18-00003. eCollection 2018 Sep.

DOI:10.4244/AIJ-D-18-00003
PMID:36483993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9706746/
Abstract

AIMS

Coronary angioscopy (CAS) is a robust imaging methodology for evaluation of vascular healing response after stenting. However, the procedure requires a guiding catheter with a diameter of more than 6 Fr, which is rather invasive at follow-up angiography. Recently, coronary angioscopes of a smaller diameter have been able to pass through a 4 Fr guiding catheter. This study aimed to investigate the feasibility and safety of slender CAS observation using a 4 Fr guiding catheter.

METHODS AND RESULTS

Thirty-three consecutive patients who underwent follow-up angiography were evaluated. Following usual angiography via the radial artery, the stent segment was observed by non-occlusive CAS through a 4 Fr guiding catheter. Low molecular weight dextran-L (4 mL/sec) was flushed from a guiding catheter to replace coronary blood. The success rate, anatomical or procedural factors related to the success, and incidence of adverse events were examined. The success rate was 84.8% (n=28/33). The luminal diameter at the orifice of the target vessel was larger in the successful than in the failed group (4.03±0.61 mm vs. 3.39±0.61 mm, respectively; p=0.009). The presence of deep engagement of the guiding catheter into the target vessel was a key factor for sufficient observation (100% in the successful group vs. 0% in the failed group; p<0.0001). No adverse events, such as dissection or acute coronary syndrome, were reported.

CONCLUSIONS

The new method of CAS through a 4 Fr guiding catheter demonstrated high feasibility and safety. This less invasive observation via CAS may be useful for stent follow-up.

摘要

目的

冠状动脉血管镜检查(CAS)是一种用于评估支架置入术后血管愈合反应的可靠成像方法。然而,该操作需要直径大于6F的引导导管,这在随访血管造影时具有较大的侵入性。最近,较小直径的冠状动脉血管镜已能够通过4F引导导管。本研究旨在探讨使用4F引导导管进行纤细CAS观察的可行性和安全性。

方法和结果

对33例连续接受随访血管造影的患者进行评估。经桡动脉进行常规血管造影后,通过4F引导导管进行非闭塞性CAS观察支架节段。从引导导管注入低分子右旋糖酐-L(4 mL/秒)以替代冠状动脉血液。检查成功率、与成功相关的解剖或操作因素以及不良事件的发生率。成功率为84.8%(n = 28/33)。成功组目标血管开口处的管腔直径大于失败组(分别为4.03±0.61 mm和3.39±0.61 mm;p = 0.009)。引导导管深入进入目标血管是充分观察的关键因素(成功组为100%,失败组为0%;p < 0.0001)。未报告诸如夹层或急性冠状动脉综合征等不良事件。

结论

通过4F引导导管进行CAS的新方法显示出高可行性和安全性。这种通过CAS进行的侵入性较小的观察可能对支架随访有用。

相似文献

1
Feasibility and safety of non-occlusive coronary angioscopic observation using a 4 Fr guiding catheter.使用4F引导导管进行非闭塞性冠状动脉血管内镜观察的可行性和安全性。
AsiaIntervention. 2018 Sep 20;4(2):110-116. doi: 10.4244/AIJ-D-18-00003. eCollection 2018 Sep.
2
First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions.首次将7F Glidesheath Slender应用于复杂经桡动脉冠状动脉介入治疗的前瞻性多中心经验。
Catheter Cardiovasc Interv. 2017 May;89(6):1014-1020. doi: 10.1002/ccd.26773. Epub 2016 Aug 27.
3
Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices.导丝鞘/导引导管联合与无导丝鞘导引导管在急性冠状动脉综合征中的应用:两种器械的倾向性匹配分析。
J Interv Cardiol. 2020 Aug 14;2020:8216831. doi: 10.1155/2020/8216831. eCollection 2020.
4
Mini-invasive strategy in acute coronary syndromes: direct coronary stenting using 5 Fr guiding catheters and transradial approach.急性冠状动脉综合征的微创策略:使用5F引导导管和经桡动脉途径进行直接冠状动脉支架置入术。
Catheter Cardiovasc Interv. 2002 Mar;55(3):340-3. doi: 10.1002/ccd.10105.
5
Percutaneous coronary interventions using a new 5 French guiding catheter: results of a prospective study.使用新型5法国引导导管的经皮冠状动脉介入治疗:一项前瞻性研究的结果
Catheter Cardiovasc Interv. 2001 Jul;53(3):308-12. doi: 10.1002/ccd.1172.
6
Thrombus-aspiration through 5 Fr guiding catheter with transradial approach in acute coronary syndromes: feasibility of a mini-invasive strategy.经桡动脉途径使用 5Fr 引导导管血栓抽吸治疗急性冠状动脉综合征:一种微创策略的可行性。
J Interv Cardiol. 2012 Aug;25(4):323-9. doi: 10.1111/j.1540-8183.2012.00731.x. Epub 2012 May 11.
7
A randomised comparison of incidence of radial artery occlusion and symptomatic radial artery spasm associated with elective transradial coronary intervention using 6.5 Fr SheathLess Eaucath Guiding Catheter vs. 6.0 Fr Glidesheath Slender.随机比较使用 6.5Fr SheathLess Eaucath 引导导管与 6.0Fr Glidesheath Slender 进行选择性经桡动脉冠状动脉介入治疗时,桡动脉闭塞和症状性桡动脉痉挛的发生率。
EuroIntervention. 2018 Apr 20;13(17):2018-2025. doi: 10.4244/EIJ-D-17-00239.
8
Feasibility and safety of transradial coronary interventions using a 6.5-F sheathless guiding catheter in patients with small radial arteries.在桡动脉细小的患者中使用6.5F无鞘导引导管进行经桡动脉冠状动脉介入治疗的可行性和安全性。
Catheter Cardiovasc Interv. 2015 Jul;86(1):51-8. doi: 10.1002/ccd.25508. Epub 2015 Mar 30.
9
Safety and feasibility of the new 5 Fr Glidesheath Slender.新型5 Fr Glidesheath Slender导管的安全性与可行性。
Cardiovasc Interv Ther. 2016 Jan;31(1):38-41. doi: 10.1007/s12928-015-0344-2. Epub 2015 Jul 4.
10
A randomized trial of 5 vs. 6 French transradial percutaneous coronary interventions.一项关于5法式与6法式经桡动脉冠状动脉介入治疗的随机试验。
Catheter Cardiovasc Interv. 2002 Oct;57(2):172-6. doi: 10.1002/ccd.10321.

本文引用的文献

1
Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.光学相干断层成像术评估极晚期药物洗脱支架血栓形成的机制。
Circulation. 2016 Feb 16;133(7):650-60. doi: 10.1161/CIRCULATIONAHA.115.019071. Epub 2016 Jan 13.
2
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.依维莫司洗脱生物可吸收支架治疗冠状动脉疾病。
N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.
3
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较(ABSORB II):一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
4
Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina.经皮冠状动脉血管镜对稳定型心绞痛患者急性冠状动脉综合征的预测
Am Heart J. 1995 Aug;130(2):195-203. doi: 10.1016/0002-8703(95)90429-8.
5
In vivo coronary angioscopy.体内冠状动脉血管镜检查。
J Am Coll Cardiol. 1983 May;1(5):1311-4. doi: 10.1016/s0735-1097(83)80145-4.
6
Angioscopic visualization of blood vessel interior in animals and humans.动物和人类血管内部的血管镜可视化。
Clin Cardiol. 1985 Feb;8(2):65-70. doi: 10.1002/clc.4960080202.
7
[First clinical experience with coronary endoscopy].[冠状动脉内镜的首次临床经验]
Dtsch Med Wochenschr. 1986 Jul 25;111(30):1135-40. doi: 10.1055/s-2008-1068597.
8
New percutaneous transluminal coronary angioscope.新型经皮腔内冠状动脉血管镜
J Am Coll Cardiol. 1989 Feb;13(2):363-8. doi: 10.1016/0735-1097(89)90513-5.
9
Percutaneous angioscopy during coronary angioplasty using a steerable microangioscope.在冠状动脉成形术期间使用可操纵微型血管镜进行经皮血管镜检查。
J Am Coll Cardiol. 1991 Jan;17(1):100-5. doi: 10.1016/0735-1097(91)90710-q.
10
Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.急性冠状动脉综合征中冠状动脉血栓的血管镜评估
N Engl J Med. 1992 Jan 30;326(5):287-91. doi: 10.1056/NEJM199201303260502.